Table 1.
Code-Subtype | Sex | Age | WHO Grade | Location of Tumor | Survival (Months) |
---|---|---|---|---|---|
Glioblastomas | |||||
003-GB | M | 67 | IV | Frontal | 49 |
022-GB | M | 75 | IV | Temporal | 11 |
027-GB | M | 67 | IV | Frontal | 35 |
038-GB | F | 68 | IV | Occipital | 23 |
Oligodendrogliomas | |||||
004-OD | M | 44 | II | Frontal | A (57) |
008-OD§ | F | 40 | II-III | Insula | A (56) |
020-OD§ | M | 69 | II-III | Frontal | A (48) |
014-AOD* | M | 39 | III-IV | Temporal | 9 |
Oligoastrocytomas | |||||
036-OA | M | 70 | II | Temporal | 7 |
015-OA§ | M | 35 | II-III | Temporal | A (51) |
025-OA§ | F | 31 | II-III | Frontal | A (44) |
039-OA | M | 51 | II-III | Frontal | A (37) |
002-OA§ | M | 42 | III | Parietal | 45 |
016-OA§ | F | 27 | III | Temporal + insula | A (51) |
026-OA†,§ | F | 61 | III | Frontal | 23 |
034-OA§ | M | 39 | III | Frontal | A (39) |
Ependymomas | |||||
035-E‡ | M | 76 | II | 4th ventricle | 4 |
A, alive (in parenthesis months since operation); E, ependymoma; F, female; M, male.
Oligodendroglioma 4 and 12 year earlier.
Anaplastic oligodendroglioma 4 years earlier.
Ependymoma 8 years earlier.
IDHR132 mutation.